King Luther Capital Management Corp Iovance Biotherapeutics, Inc. Transaction History

King Luther Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$20.35 - $26.63 $2.32 Million - $3.04 Million	-114,210 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $381,550 - $772,680	23,365 Added 25.72%	114,210 $2.97 Million
Q1 2021 May 12, 2021	BUY	$28.67 - $52.59 $969,476 - $1.78 Million	33,815 Added 59.29%	90,845 $2.88 Million
Q4 2020 Feb 10, 2021	BUY	$28.04 - $50.26 $1.6 Million - $2.87 Million	57,030 New	57,030 $2.65 Million

342

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $573M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on King Luther Capital Management Corp with notifications on news.